Benefits
Cardiovascular support
Clinical trials show pine bark extract improves endothelial function, reduces blood pressure modestly, and supports arterial elasticity in adults with cardiovascular risk factors. Effect sizes are clinically meaningful as adjunct therapy or for those with mild hypertension.
Venous insufficiency and varicose veins
Pine bark extract reduces symptoms of chronic venous insufficiency, including leg heaviness, edema, and varicose vein symptoms. Mechanism involves vascular tone improvement and reduced capillary fragility. Useful adjunct to compression therapy.
Cognitive function support
Trials in older adults and adults with mild cognitive concerns show pine bark extract supports memory, attention, and executive function. Mechanism involves cerebral blood flow support and antioxidant protection of neural tissue.
ADHD symptom modulation
Clinical trials in children with ADHD show pine bark extract supplementation may improve attention and reduce hyperactivity symptoms over 4-8 weeks of use. Effect sizes are modest but useful as complementary support. Not a replacement for stimulant medications when those are clinically indicated.
Asthma adjunct support
Pine bark extract supplementation may reduce asthma symptoms and inhaler use in some patients. Mechanism involves anti-inflammatory effects on airway tissue. Adjunct to standard asthma management rather than replacement.
Skin health and photoprotection
Pine bark extract supports skin elasticity, hydration, and may provide modest photoprotection from UV damage. Mechanism involves antioxidant protection and collagen support. Useful for general skin aging applications.
Antioxidant activity
Pine bark proanthocyanidins are among the most potent natural antioxidants — scavenge free radicals and support cellular antioxidant defenses. Generic dietary antioxidant benefits suitable for long-term use.
Source species and standardization
French maritime pine (Pycnogenol®) has the most research; American white pine and Korean red pine extracts are less studied. Quality forms standardize to ≥85% proanthocyanidins. Generic extracts at proper standardization produce similar mechanisms; Pycnogenol® has the trial-grade evidence depth.
Mechanism of action
Endothelial function and nitric oxide support
Pine bark proanthocyanidins support endothelial nitric oxide production and vascular tone. Mechanism foundation for the cardiovascular and venous applications.
Antioxidant and anti-inflammatory effects
Proanthocyanidins scavenge free radicals and reduce inflammatory cytokines. Multi-pathway anti-inflammatory effects support the breadth of clinical applications.
Cerebral blood flow and cognitive support
Pine bark extract enhances cerebral blood flow through vascular effects. Mechanism contributes to the cognitive function support seen across trials in older adults and ADHD populations.
Capillary stability
Proanthocyanidins reduce capillary fragility and permeability — important for venous insufficiency applications and varicose vein symptom management.
Clinical trials
Multiple clinical trials document pine bark extract supports endothelial function, blood pressure, and venous health. Effect sizes consistent across French maritime pine and other species at proper standardization.
Trials in older adults and adults with cognitive concerns show pine bark extract supports memory and attention. Effects build over weeks of consistent use.
Clinical trials in children with ADHD show pine bark extract may improve attention and reduce hyperactivity over 4-8 weeks. Mechanism involves antioxidant and vascular support rather than stimulant effects.
Clinical trials in asthma patients show pine bark extract may reduce symptoms and inhaler use as adjunct to standard therapy. Effect sizes are modest but useful for complementary management.